LINEVOL

Linevol is a biotechnology company and a subsidiary of Lineage Cell Therapeutics, dedicated to the development of lineage-specific extracellular vesicles (EVs), commonly referred to as exosomes. The company utilizes Lineage's proprietary cell therapy platform to manufacture highly characterized and purified EVs from specialized cell lines. These EVs are designed to carry therapeutic payloads or exhibit intrinsic biological activities for the treatment of various diseases, including oncology and neurological disorders. By leveraging a scalable manufacturing process, Linevol aims to overcome the traditional challenges associated with exosome production and characterization. The company represents a strategic expansion of Lineage's capabilities into the emerging field of EV-based biologics.